Glimsite MP 1 Tablet ER
By Glimsite MP
Rx
10 Tablet ER in a Strip

Composition
Glimepiride(1mg) + Metformin(500mg) + Pioglitazone(15mg)

Manufacturer - Sanofi India Ltd
Sanofi House, CTS No.117-B, L&T Business Park, Saki Vihar Road, Powai, Mumbai 400072

Expires on or after
October, 2025

liver
When using Glimsite MP 1 Tablet ER, it is important to be cautious if you have liver disease. Patients with liver issues may require a dose adjustment when taking Glimsite MP 1 Tablet ER, so it's best to consult your doctor before use. However, individuals with severe liver disease are advised not to use Glimsite MP 1 Tablet ER. It's crucial to follow your healthcare provider's guidance closely for your safety.

kidney
Glimsite MP 1 Tablet ER should be used carefully in patients with kidney issues. Adjusting the dose may be necessary. Refrain from using it in severe kidney problems. Monitor kidney function regularly when on this medication.

alcohol
Do not drink alcohol while taking Glimsite MP 1 Tablet ER.

driving
When taking Glimsite MP 1 Tablet ER, be cautious when driving. If you experience low or high blood sugar symptoms, refrain from driving as it could affect your ability to focus and react effectively.

pregnancy
Glimsite MP 1 Tablet ER could be harmful during pregnancy due to limited human studies and observed risks in animal studies. Consult your doctor for guidance as they will assess the benefits and potential risks before prescribing this medication to you.

breastfeeding
Caution Glimsite MP 1 Tablet ER is likely unsafe while breastfeeding. Limited data indicates the drug can pass into breastmilk and potentially harm the infant.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | ANTI DIABETIC |
Action Class | - |
₹64
Inclusive of all taxes
Content verified by

Dr. Mansi Chaudhari
MBBS - General Medicine
Last update on 01-Oct-2024